An Overview of FGF-23 as a Novel Candidate Biomarker of Cardiovascular Risk

An Overview of FGF-23 as a Novel Candidate Biomarker of Cardiovascular Risk

Fibroblast growth factor-23 (FGF)-23 is a phosphaturic hormone involved in mineral bone metabolism that helps control phosphate homeostasis and reduces 1,25-dihydroxyvitamin D synthesis. Recent data have highlighted the relevant direct FGF-23 effects on the myocardium, and high plasma levels of FGF-...

Full description

Bibliographic Details
Main Authors: Sara Vázquez-Sánchez, Jonay Poveda, José Alberto Navarro-García, Laura González-Lafuente, Elena Rodríguez-Sánchez, Luis M. Ruilope, Gema Ruiz-Hurtado
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Physiology
Subjects:
FGF-23
FGFR
heart
LVH
heart failure – pharmacological treatment – systolic dysfunction
Online Access:https://www.frontiersin.org/articles/10.3389/fphys.2021.632260/full

Internet

https://www.frontiersin.org/articles/10.3389/fphys.2021.632260/full

Similar Items